Dedham, MA, United States of America

Russell Alan Miller

USPTO Granted Patents = 2 


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Russell Alan Miller: Innovator in Patent Development**

Introduction

Russell Alan Miller is a distinguished inventor based in Dedham, Massachusetts, who has made significant contributions to the field of pharmaceutical innovations. With two patents to his name, Miller's work focuses on groundbreaking therapies aimed at treating serious health conditions.

Latest Patents

Miller's latest patents involve the development of BCKDK inhibitors. These compounds are characterized by a specific Formula I, where the molecular groups R, R, and R are precisely defined. The primary applications of these inhibitors include their use in combating branched-chain alpha keto acid dehydrogenase kinase, along with the creation of pharmaceutical compositions derived from these inhibitors. Notably, these therapeutic agents are being explored for their potential to treat conditions such as diabetes, Non-Alcoholic Steatohepatitis (NASH), and heart failure.

Career Highlights

Miller is currently affiliated with Pfizer Corporation, a global leader in the pharmaceutical industry. His role at Pfizer provides him with a platform to refine and advance his innovative ideas, driving research and development in treatments that could significantly enhance patient outcomes.

Collaborations

Throughout his career, Miller has collaborated with various talented professionals within his organization. Notable coworkers include Samit Kumar Bhattacharya and Leanne Marie Buzon, who have contributed their expertise to further the research initiatives related to his patents. These collaborations underscore the importance of teamwork in driving scientific progression.

Conclusion

Russell Alan Miller exemplifies the spirit of innovation in the pharmaceutical sector. With his patents focusing on BCKDK inhibitors, Miller is paving the way for new therapeutic solutions that may substantially impact the management of debilitating health conditions. His work, in collaboration with esteemed colleagues at Pfizer Corporation, serves as an inspiration for future inventors in the field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…